This inventor holds 1 USPTO granted patent. Top assignee: Yasutoshi Muto. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Kaito Tsurumi: Innovator in Anticarcinogenic Drug Composition
Introduction
Kaito Tsurumi is a notable inventor based in Gifu, Japan. He has made significant contributions to the field of medicine, particularly in the development of anticarcinogenic drug compositions. His work aims to combat various forms of cancer, showcasing his dedication to improving health outcomes.
Latest Patents
Kaito Tsurumi holds a patent for an anticarcinogenic drug composition. This innovative composition effectively inhibits the recurrence of hepatocellular carcinoma and addresses the occurrence of other cancers, including cervical carcinoma intraepitheliale, lung adenocarcinoma, and mammary tumors. The composition is characterized by its high safety profile and contains 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid or a salt thereof. He has 1 patent to his name.
Career Highlights
Throughout his career, Kaito Tsurumi has focused on research that aims to provide effective solutions for cancer treatment. His innovative approach has positioned him as a key figure in the medical research community.
Collaborations
Kaito Tsurumi has collaborated with notable colleagues, including Yasutoshi Muto and Hisataka Moriwaki. These partnerships have enhanced his research efforts and contributed to the advancement of his inventions.
Conclusion
Kaito Tsurumi's work in developing anticarcinogenic drug compositions highlights his commitment to fighting cancer and improving patient safety. His contributions to the field are invaluable and reflect the importance of innovation in medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile